This spawned the next generation of 21st century high CBD cannabis. Why do people get high on this stuff? I underestimated this strain - the THC was listed as incredibly high and my God, it was! Flowering times for cannabis vary greatly according to strain. Key Contribution: Cannabis sativa is an herbaceous shrub used as a medicine and for recreational and spiritual purposes since ancient times. Blue Zushi is a hybrid Indica dominant cannabis seed variety that clearly shows a mix of both an Indica and a Sativa parent in appearance. Marijuana is known by a variety of other names, including pot, tea, grass, and weed. 17 period, which is when recreational weed went on sale in Canada. The company attributed this decline to the 10% excise tax on recreational weed sales, as well as lower wholesale pricing. Having provided sales guidance in early January of between 50 million Canadian dollars (CA$50 million) and CA$55 million for Q2 2019, Aurora Cannabis delivered revenue near the upper end of that range, with CA$54.2 million in net sales, up 363% from the year-ago quarter. Aurora reported international sales of 2.9 million in Canadian dollars (around US$2.2 million) in the last quarter compared to Canopy Growth's total international sales of CA$2.7 million (around US$2 million).
Canopy Growth (CGC 2.25%) claims the highest market share in the Canadian recreational pot market. The Canadian adult-use recreational marijuana market is still in its early days. That's a tiny difference, especially considering how early it still is for global medical marijuana markets. There's one other thing that investors considering buying Aurora Cannabis should know: how big the global marijuana market could be. Well, here's the thorn in the rose: Aurora has diluted the value of its existing shares like crazy by issuing new shares as part of bought-deal financing transactions. Although Aurora is tracking toward profitability, it could still have to raise additional capital for expansion through bought-deal financing in the future. Interestingly enough, recreational pot sales still took a back seat to medical marijuana sales in Aurora's latest quarter. Although it's still early in the rollout of pot products, the per-gram price of dried cannabis tumbled 21% year over year and 26% from the sequential first quarter. Aurora Cannabis is arguably the most popular, if not the most polarizing, pot stock of the industry. The biggest drawback for Aurora from an international perspective is in the U.S. Aurora can't enter the U.S.
Canopy has already announced plans to jump into the U.S. Big alcoholic beverage maker Constellation Brands has poured over $4 billion into Canopy and If you have any sort of inquiries concerning where and how you can utilize full guide, you can call us at the site. owns a 38% stake in the company. Another area where Aurora is indisputably behind Canopy Growth is in strategic partnerships. Peltz's role will be to help the company find out more partners in what he called "mature players in consumer and other market segments." If these efforts are successful, Aurora could have some significant catalysts ahead. As you navigate through our platform, you'll find out more tales that resonate with you, stories that inspire, and experiences that encourage you to share your own. All the company has to do it capture a small share of the global market to have a lot of room to run. However, Aurora's executives would tell you that this dilution from issuing new shares was a necessary evil to expand rapidly in order to position the company for the long term.
Also, the company has nearly $500 million in convertible notes outstanding that could be converted into shares over the next few years, causing even read more dilution. The company also is active in 24 countries spanning five continents. During Q2, Aurora Cannabis realized a gross profit of CA$28.4 million prior to fair-value adjustments, but walked away with a net CA$3.7 million benefit from fair-value adjustments to its biological assets (i.e. marijuana plants) when all was said and done. Thus, its gross profit lifted to CA$32.1 million. Its ancillary revenue channels, which include greenhouse design and construction services, patient counseling, analytical testing services, and horizontally integrated business revenue, totaled CA$6.6 million in Q2 2019, up from just CA$1.9 million in the year-ago quarter. Although this was slightly ahead of Wall Street estimates, it should be noted that Wall Street had been expecting CA$67.4 million before the company's January-issued sales update. Two pieces of legislation regarding cannabis are currently circulating through the District’s system of government, both of which would include provisions to legalize recreational sales and establish social equity programs. We know already, though, that two companies have emerged as the clear leaders based on their latest quarterly updates. There are several main extraction methods, again with two main categories, splitting them into solvent and non-solvent processes.